DPP4 and type 2 diabetes mellitus: Sitagliptin (SIT), an inhibitor of dipeptidyl peptidase-4 (DPP-4) mainly used for type II diabetes mellitus, was reported to antagonize IR injury in the liver (9), kidney (10), intestine (11), and testis (4).